These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27572868)

  • 21. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
    Zivadinov R; Leist TP
    J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Measurement of tissue damage and recovery within new T2w lesions in pediatric- and adult-onset multiple sclerosis.
    Ghassemi R; Brown R; Banwell B; Narayanan S; Arnold DL;
    Mult Scler; 2015 May; 21(6):718-25. PubMed ID: 25480858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI measures of neuroprotection and repair in multiple sclerosis.
    Inglese M
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S16-23. PubMed ID: 22206761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI correlates of cognitive dysfunction in multiple sclerosis patients.
    Rovaris M; Filippi M
    J Neurovirol; 2000 May; 6 Suppl 2():S172-5. PubMed ID: 10871808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.
    Barkhof F; Bruck W; De Groot CJ; Bergers E; Hulshof S; Geurts J; Polman CH; van der Valk P
    Arch Neurol; 2003 Aug; 60(8):1073-81. PubMed ID: 12925362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
    Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
    J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions.
    Nayak NB; Salah R; Huang JC; Hathout GM
    Acta Neurol Scand; 2014 Mar; 129(3):198-203. PubMed ID: 23980614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth.
    Aubert-Broche B; Fonov V; Narayanan S; Arnold DL; Araujo D; Fetco D; Till C; Sled JG; Banwell B; Collins DL;
    Neurology; 2014 Dec; 83(23):2140-6. PubMed ID: 25378667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
    Tauhid S; Chu R; Sasane R; Glanz BI; Neema M; Miller JR; Kim G; Signorovitch JE; Healy BC; Chitnis T; Weiner HL; Bakshi R
    J Neurol; 2015 Nov; 262(11):2425-32. PubMed ID: 26205635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
    Rovaris M; Comi G; Filippi M
    J Neurol Sci; 2006 Jun; 245(1-2):111-6. PubMed ID: 16626748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric multiple sclerosis.
    Chabas D; Green AJ; Waubant E
    NeuroRx; 2006 Apr; 3(2):264-75. PubMed ID: 16554264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis.
    Oommen VV; Tauhid S; Healy BC; Chua AS; Malik MT; Diaz-Cruz C; Dupuy SL; Weiner HL; Chitnis T; Bakshi R
    J Neuroimaging; 2016; 26(2):184-7. PubMed ID: 26445919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
    Hummel HM; Brück W; Dreha-Kulaczewski S; Gärtner J; Wuerfel J
    Mult Scler; 2013 Sep; 19(10):1330-5. PubMed ID: 23828866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetisation transfer imaging in multiple sclerosis.
    Filippi M; Rovaris M
    J Neurovirol; 2000 May; 6 Suppl 2():S115-20. PubMed ID: 10871798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations between magnetization transfer metrics and other magnetic resonance abnormalities in multiple sclerosis.
    Rovaris M; Horsfield MA; Filippi M
    Neurology; 1999; 53(5 Suppl 3):S40-5. PubMed ID: 10496210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Magnetic resonance imaging correlates of cognitive dysfunction in patients with multiple sclerosis].
    Filippi M
    Rev Neurol; 2000 Jun 16-30; 30(12):1253-6. PubMed ID: 10935260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.